R&D Changing Faces: Pharma and biotech, January 2026 The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
R&D Changing Faces: Pharma and biotech hires, November and Decem... In our final batch of Changing Faces columns from 2025, we’re detailing a flurry of senior leadership appointments in recent months.
R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
Sales & Marketing Changing Faces – Pharma and biotech hires – August and Septe... It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.
R&D Changing Faces – Pharma and Biotech Hires for July 2025 Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.
R&D Changing Faces – Pharma and biotech hires for June 2025 Read on for some of the key appointments of last month. Bristol Myers Squibb adds two executive leaders.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.